N. Pagidipati

Rationale and design of “Hearts & Parks”: study protocol for a pragmatic randomized clinical trial of an integrated clinic-community intervention to treat pediatric obesity

Nathan A. Bihlmeyer, H. Dressman, W. Kraus, 2020, BMC Pediatrics.

Lipoprotein(a) Testing Patterns in a Large Health System.

S. Rhodes, S. Kent, E. Peterson, 2021, The American journal of cardiology.

Alirocumab after acute coronary syndrome in patients with a history of heart failure

Deepak L. Bhatt, R. Diaz, H. White, 2021, European heart journal.

Towards a personalised approach for obesity treatment: one size does not fit all

Neha Pagidipati, Michelle D. Kelsey, N. Pagidipati, 2021, Heart.

Risk Factor Burden and Long‐Term Prognosis of Patients With Premature Coronary Artery Disease

Manesh R. Patel, Svati H Shah, M. Roe, 2020, Journal of the American Heart Association.

Clinical progress note: Indications for and management of sodium-glucose cotransporter-2 (SGLT-2) inhibitors in hospitalized patients.

Susan E. Spratt, Daniel L. Edmonston, S. S. Sata, 2022, Journal of hospital medicine.

Accelerated Epigenetic Aging Is Associated With Multiple Cardiometabolic, Hematologic, and Renal Abnormalities: A Project Baseline Health Substudy

K. Mahaffey, N. Pagidipati, R. Chatterjee, 2023, Circulation. Genomic and precision medicine.

Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive Medications.

R. Wilensky, J. Stehli, K. Kario, 2023, Journal of the American College of Cardiology.